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A SPECIFIC FRACTION ofimmunoglobulin
G (JgG) binds to blood polymorphonuclear
neutrophils (PMNs) and stimulates their
phagocytic activity (Fidalgo & Najjar,
1967). This phagocytosis-stimulating ac-
tivity is confined to a small peptide
termed tuftsin, which has been isolated
from leucophilic IgG and characterized
biochemically (Najjar & Nishioka, 1970).
The peptide, whose sequence has been
determined as Thr-Lys-Pro-Arg (Nishioka
et al., 1972, 1973a), has been chemically
synthesized by various investigators
(Nishioka et al., 1972, 1973b; Spirer et al.,
1975; Yajima et al., 1975; Okamoto &
Shimamura, 1976; Konopinska et al.,
1977; Fridkin et al., 1977). The physio-
logical significance of tuftsin has been
demonstrated in splenectomized dogs and
humans (Najjar & Constantopoulos, 1972;
Constantopoulos et al., 1973a; Spirer et
al., 1977a, b) and also in patients with
acute myelocytic leukemia (Constanto-
poulos et al., 1973b) whose low levels of
serum tuftsin coincide with a high inci-
dence of infections. Its exigency is further
demonstrated in patients with a con-
genitaltuftsinabnormality. Suchinfection-
susceptible individuals carry a peptide
which competes with tuftsin (Najjar &
Constantopoulos, 1972; Constantopoulos
et al., 1973a). In addition to human and
dog PMNs, tuftsin has been shown to
stimulate the phagocytic activity of
guinea-pig peritoneal granulocytes, mouse
peritoneal macrophages, and rabbit alveo-
lar macrophages (Constantopoulos &
Najjar, 1972). Tuftsin also enhances the
reduction of nitrous blue tetrazolium by
human PMNs (Spirer et al., 1975; Fridkin
et al., 1977), the random migration of
human mononuclear cells (Nishioka, 1976,
1978) and antigen-specific macrophage-
dependent education of T lymphocytes
(Tzehoval et al., 1978). Recently, the
presence ofspecific binding sites for tuftsin
on human PMNs and monocytes has also
been revealed (Stabinsky et al., 1978).
We present here the results of a pre-
liminary study of the immunological
functions of tuftsin, which indicate that
this peptide can have immunological
anti-tumour effects. These results suggest
a potential role for tuftsin as an immuno-
therapeutic agent, not only for patients
with Hodgkin's and other diseases requir-
ing splenectomy, but also for patients with
other tumour types.
In order to examine the anti-tumour
activity of tuftsin, an in vivo syngeneic
system ofDBA mice and L1210 leukaemia
cells was used. Control mice were injected
i.p. with 104 L1210 cells. Experimental
mice also received simultaneously in addi-
tion, 0-2 ,ug of tuftsin. The Figure depicts
the result obtained from this experiment.
The mean survival of the control group
was 101 days, whereas that of tuftsin-
injected group was 12-0 days (t test,
P<0 0005). This experiment was re-
peated 3 more times. In all experiments
the survival curve consistently indicatedANTI-TUMOUR EFFECT OF TUFTSIN
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FIG. The effects oftuftsin on survival cur ves
of DBA mice challenige(d with L12 10
leukaemia cells. DBA mice weighing , 20 ,
were (livi(le(l into 2 gIroups of 10 mice.
Control mice ( ) Mwere transplanted i.p.
Nxxith 03 ml sterile salinie conitaining 104
L1210 leukaemia cells. The experimental
group (---) receivedl, in adldition, 0-2 pg
ttnfts;ii inito the peritolleuLm simultaneously.
a significantly longer survival time in
mice receiving tuftsin. A dose-response
experiment indicated that there was no
significant difference in the survival time
between 0f2, 2, and 20 jig tuftsin, but
0 02 jug tuftsin produced a shorter mean
survival time.
Knowing that tuftsin can stimulate
monocytes (Nishioka, 1976, 1978) and
macrophages (Constantopoulos & Najjar,
1972) in addition to PMNs (Fidalgo &
Najjar, 1967; Najjar and Nishioka, 1970),
we attempted to examine another property
ofthe activated macrophages, the morpho-
logical alteration or spreading after injec-
tion of tuftsin into the peritoneal cavity.
CBA mice were injected with either 1 ml
of sterile saline containing 10 [g of
tuftsin or 1 ml of sterile saline alone.
After 4 and 7 days, 2 mice were killed.
The harvested pooled peritoneal exudate
was plated on plastic Petri dishes, incu-
bated in Hanks' solution for 2 h at 37°C
and the phase-dark cells counted as
described by Leonard & Skeel (1976).
Four days after tuftsin injection, the mean
percentages ofphase-dark cells from saline
alone and tuftsin-injected mice were 35
and 3900 respectively. However, 7 days
after injection these values were 49 and
72 no respectively, indicating a marked
23
enhancement (P<0 0005) of macrophage
spreading by tuftsin. This experiment was
repeated twice. Each time, significant
enhancement of macrophage spreading
was seen in the tuftsin-treated animals.
In addition, the total leucocyte count in
the pooled peritoneal exudate increased
from 1U4x 107 at Day 3 to 2 5x 107 at
Day 7 after tuftsin injection, whereas the
exudate from saline-injected mice gave
15x 107 at both Days 3 and 7.
In view of these observations, the effect
of tuftsin on the cytotoxicity ofperitoneal
macrophages against IL1210 cells was
examined in vitro by adapting method
described by Bean et al. (1976). Trans-
plantable leukaemia cells were adapted
for growth in minimum essential medium
with 15% foetal calf serum (MEM), and
labelled in 100 HuCi L-[2,3-H] proline per
ml MEM (free of unlabelled proline) for
18 h. The labelled target cells were
washed with MEM containing 2%o non-
essential amino acid (NEAA). Unstimu-
lated heparinized peritoneal macrophages
obtained from DBA mice were washed,
suspended in MEM-NEAA, dispensed into
wells of a microcytotoxicity plate (105
macrophages per well) and incubated at
37°C for 90 min. Non-adherent cells were
then removed by washing each well X 4
with warm Hanks' solution. The mono-
layered macrophages were incubated with
0, 1 or 10 ,ug tuftsin per ml MEM-NEAA
(6 wells for each) at 37°C for 18 h and
washed twice with MEM-NEAA to re-
move the remaining tuftsin. One fifth of
1 ml of MEM-NEAA containing 2,000
labelled Ll1210 cells was then introduced
into each well to produce a ratio ofmacro-
phages:target cells of 50:1. After either
48 or 72 h incubation at 37°C, the L1l210
cells were collected from each well by a
harvester and the radioactivity in the
remaining viable L1210 cells counted
using a liquid scintillation counter. As
shown in the Table, the macrophages
treated with 10 Htg tuftsin per ml showed
consistently significant higher cytotoxicity
than the untreated macrophages.
To rule out the possibility of the direct
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TABLE.-In vitro effect of tuftsin on cytotoxicity of mouse peritoneal macrophages against
LI210 leukaemia cells
Tuftsin
concentration Incubation % Cytotoxicity P
Expt (pg/ml) (h) enhancement±s.e.* (t test)
1 1 48 2-6±1-9 <0-4
10 12-0±2-1 <0 05
2 1 48 3-9±2-1 <0-1
10 11-4+0-8 <0 0005
3 1 48 9-8±2-7 <0-025
10 16-6±2-2 <0-0025
4 1 72 32-3±1-3 <0-0005
10 26-5±6-7 <0 005
ct/min in control (macrophages+L1210 cells)
* -ct/min (tuftsin-treated macrophages+L1210 cells) x 100 ct/min in control (macrophages+L1210 cells)
cytotoxicity of tuftsin to the target cells,
L1210 cells were incubated with [methyl-
3H] thymidine in the absence or presence
of 2 or 20 ,ug tuftsin per ml of MEM for
24 h. No significant reduction of labelled
thymidine incorporation was found in the
presence of either 2 or 20 ,ug tuftsin per
ml.
Although enhancement of macrophage
cytotoxicity by tuftsin in vitro was not
very high under the conditions employed,
the above data together suggest that
activation of the peritoneal macrophages
by tuftsin is at least partially responsible
for the anti-tumour activity of tuftsin.
In addition to the cytotoxicity, possible
cytostatic effects of activated macro-
phages on target cells may play a role
in vivo. Furthermore, other immuno-
logical effector cells may also be involved
in the in vivo tuftsin effect. Further
investigation into the roles of tuftsin
in biological and immunological systems
appear highly desirable.
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